hrs4r
Quiero donar
Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, Nam BH, Ramos R, Sala J, Solanas P, Cordón F, Gené-Badia J, D'Agostino RB

Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2007, 61, 40-47 dx.doi.org/10.1136/jech.2005.038505
Ferrer-Soler L, Vazquez-Martin A, Brunet J, Menendez JA, De Llorens R, Colomer R

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 20, 3-10
López-Bermejo A, Khosravi J, Ricart W, Castro A, Hwa V, Pratt KL, Casamitjana R, Rosenfeld RG, Fernández-Real JM

Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/MAC25) is linked to endothelial-dependent vasodilation in high-ferritin type 2 diabetes

Diabetes Care, 2007, 30, 1615-1617 dx.doi.org/10.2337/dc06-1905
Fernández-Real JM, Moreno JM, Chico B, López-Bermejo A, Ricart W

Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance

Diabetes Care, 2007, 30, 616-621 dx.doi.org/10.2337/dc06-1581
Fernández-Real JM, Ferri MJ, Vendrell J, Ricart W

Burden of infection and fat mass in healthy middle-aged men

Obesity, 2007, 15, 245-252 dx.doi.org/10.1038/oby.2007.541
Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, Serena J, Vivancos J, Nombela F, Lorenzo P, Lizasoain I, Moro MA

Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27, 1327-1338 dx.doi.org/10.1038/sj.jcbfm.9600438
Menendez JA, Vazquez-Martin A, Colomer R, Brunet J, Carrasco-Pancorbo A, Garcia-Villalba R, Fernandez-Gutierrez A, Segura-Carretero A

Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells.

BMC CANCER, 2007, 7, 80-80 dx.doi.org/10.1186/1471-2407-7-80
López-Bermejo A, Chico-Julià B, Castro A, Recasens M, Esteve E, Biarnés J, Casamitjana R, Ricart W, Fernández-Real JM

Alpha defensins 1, 2, and 3 - Potential roles in dyslipidemia and vascular dysfunction in humans

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27, 1166-1171 dx.doi.org/10.1161/ATVBAHA.106.138594
Fernández-Real JM, Moreno JM, López-Bermejo A, Chico B, Vendrell J, Ricart W

Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity

Diabetes Care, 2007, 30, 604-608 dx.doi.org/10.2337/dc06-1138
Castellanos M, Sobrino T, Millán M, García M, Arenillas J, Nombela F, Brea D, Perez de la Ossa N, Serena J, Vivancos J, Castillo J, Dávalos A

Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.

Stroke, 2007, 38, 1855-1859 dx.doi.org/10.1161/STROKEAHA.106.481556
Vazquez-Martin A, Colomer R, Menendez JA

Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.

EUROPEAN JOURNAL OF CANCER, 2007, 43, 1117-1124 dx.doi.org/10.1016/j.ejca.2007.01.037
Lehnart SE, Ackerman MJ, Benson DW, Brugada R, Clancy CE, Donahue JK, George AL, Grant AO, Groft SC, January CT, Lathrop DA, Lederer WJ, Makielski JC, Mohler PJ, Moss A, Nerbonne JM, Olson TM, Przywara DA, Towbin JA, Wang LH, Marks AR

Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function.

Circulation, 2007, 116, 2325-2345 dx.doi.org/10.1161/CIRCULATIONAHA.107.711689
Esteve E, Castro A, López-Bermejo A, Vendrell J, Ricart W, Fernández-Real JM

Serum interleukin-6 correlates with endothelial dysfunction in healthy men independently of insulin sensitivity

Diabetes Care, 2007, 30, 939-945 dx.doi.org/10.2337/dc06-1793
López-Bermejo A, Hernández-Aguado I, Vera IJ, Recasens M, Esteve E, Casamitjana R, Ricart W, Fernández-Real JM

Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects.

THROMBOSIS AND HAEMOSTASIS, 2007, 97, 240-244 dx.doi.org/10.1160/TH06-08-0461
Grau M, Subirana I, Elosua R, Solanas P, Ramos R, Masiá R, Cordón F, Sala J, Juvinyà D, Cerezo C, Fitó M, Vila J, Covas MI, Marrugat J

Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain.

EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14, 653-659 dx.doi.org/10.1097/HJR.0b013e3281764429
Castellanos M, Serena J

Applicability of biomarkers in ischemic stroke.

CEREBROVASCULAR DISEASES, 2007, 24 Suppl 1, 7-15 dx.doi.org/10.1159/000107374
Menendez JA, Lupu R

Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?

BREAST CANCER RESEARCH, 2007, 9, 111-111 dx.doi.org/10.1186/bcr1773
Vilalta-Franch J, Lopez-Pousa S, Garre-Olmo J, Turon-Estrada A, Pericot-Nierga I

Heterogeneidad clinica de la enfermedad de Alzheimer segun la edad de inicio.

REVISTA DE NEUROLOGIA, 2007, 45, 67-72 dx.doi.org/10.33588/rn.4502.2007101
Mansour F, Thibault B, Dubuc M, Guerra PG, Macle L, Brugada R, Roy D, Talajic M, Khairy P

Shocking truths about implantable cardioverter defibrillator monitoring zones.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2007, 30, 1146-1148 dx.doi.org/10.1111/j.1540-8159.2007.00827.x
Manco M, Fernandez-Real JM, Equitani F, Vendrell J, Valera Mora ME, Nanni G, Tondolo V, Calvani M, Ricart W, Castagneto M, Mingrone G

Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92, 483-490 dx.doi.org/10.1210/jc.2006-0960

Conoce el IDIBGI!

menu